Lewis Bioserch Pharma Pvt. Ltd. is an established pharmaceutical company offering PCD Pharma Franchise opportunities for IV and injectable products across India. The company is based in Barwala, Panchkula, Haryana, and operates with a focus on manufacturing and supplying quality pharmaceutical formulations for healthcare professionals, distributors, and franchise partners. Its product portfolio covers multiple therapeutic segments, including gynecology, pediatrics, orthopedics, general medicine, nutraceuticals, antibiotics, and injectables.

Lewis Bioserch has a dedicated injection range that includes IV and injectable formulations such as pantoprazole, ceftriaxone, ceftriaxone-sulbactam, ceftriaxone-tazobactam, meropenem, amikacin, ondansetron, and piperacillin-tazobactam. This broad injectable portfolio provides franchise partners with products suitable for hospital, clinical, and pharmaceutical distribution requirements.

The company states that it operates a WHO and GMP certified production unit, along with testing laboratories, R&D facilities, warehousing, and packaging infrastructure. Its manufacturing practices emphasize quality management, regulatory compliance, product testing, and consistent dosage-form properties.

With a diverse portfolio of around 300 products, experienced professionals, and a strong focus on quality and customer service, Lewis Bioserch Pharma provides business opportunities for entrepreneurs looking for a reliable PCD Pharma Franchise Company for IV Infusion and injectable products in India.